Clinical trials held at Memorial Sloan Kettering Cancer Center in New York may prove to be a giant step toward finding a cure for cancer. As per reports emerging from the US, a drug named Dostarlimab is the cure.

Not one or two but 18 patients who were given the drug for six months have been completely cured of rectal cancer. "Dostarlimab is a drug with laboratory-produced molecules that act as substitute antibodies in the human body," Outlook quoted a medical report as saying.

"A trial group of people with rectal cancer just experienced something of a scientific miracle: their cancer vanished after an experimental treatment," wrote NPR today, reporting on the clinical trial.

But some doctors and scholars are cautious. "The wonder drug Dostarlimab, which is a monoclonal antibody drug, works for those with tumors with a specific genetic makeup known as mismatch repair-deficient (MMRd) or microsatellite instability (MSI) which occur in 5-10% of colorectal cancer patients," wrote Dr Ahmed Kalebi. The drug seems to be extremely expensive. If that is the case, patients in low- and middle-income countries like India will opt for surgery rather than drug.